XML 45 R25.htm IDEA: XBRL DOCUMENT v3.22.0.1
DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
12 Months Ended
Dec. 31, 2021
DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  
Schedule of customer concentration

Years Ended December 31, 

    

2021

    

2020

    

2019

 

Customer 1

29

%

31

%

32

%

Customer 2

23

%

24

%

25

%

Customer 3

16

%

19

%

23

%

Schedule of disaggregation of revenue and revenue recognized

Products and Services

Years Ended December 31, 

(in thousands)

    

2021

    

2020

    

2019

Sales of generic pharmaceutical products

$

143,571

$

147,257

$

128,729

Sales of branded pharmaceutical products

 

47,561

 

47,960

 

63,767

Sales of contract manufactured products

 

10,042

 

9,221

 

11,139

Royalties from licensing agreements

 

11,795

 

1,396

 

807

Product development services

 

1,310

 

1,858

 

1,125

Other

 

1,857

 

783

 

980

Total net revenues

$

216,136

$

208,475

$

206,547

Timing of Revenue Recognition

Years Ended December 31, 

(in thousands)

    

2021

    

2020

    

2019

Performance obligations transferred at a point in time

$

214,826

$

206,617

$

205,422

Performance obligations transferred over time

 

1,310

 

1,858

 

1,125

Total

$

216,136

$

208,475

$

206,547

Schedule of accruals and allowances

The following table summarizes activity in the consolidated balance sheets for accruals and allowances for the years ended December 31, 2021, 2020, and 2019:

Accruals for Chargebacks, Returns, and Other Allowances

Administrative

Prompt

Government

Fees and Other

Payment

(in thousands)

    

Chargebacks

    

Rebates

    

Returns

    

Rebates

    

Discounts

Balance at December 31, 2019 (1)

$

49,882

$

8,901

$

16,595

$

8,281

$

2,549

Accruals/Adjustments

 

408,265

 

14,240

 

30,333

 

37,588

 

14,347

Credits Taken Against Reserve

 

(369,401)

(15,315)

 

(19,773)

 

(36,963)

 

(13,057)

Balance at December 31, 2020 (1)

$

88,746

$

7,826

$

27,155

$

8,906

$

3,839

Accruals/Adjustments

 

492,374

 

15,308

 

24,081

 

35,225

 

15,633

Credits Taken Against Reserve

 

(487,054)

(17,642)

 

(15,405)

 

(31,031)

 

(14,830)

Balance at December 31, 2021 (1)

$

94,066

$

5,492

$

35,831

$

13,100

$

4,642

(1)Chargebacks are included as a reduction to accounts receivable, net of chargebacks and other allowances in the consolidated balance sheets. Administrative Fees and Other Rebates and Prompt Payment Discounts are included as a reduction to accounts receivable, net of chargebacks and other allowances or accrued expenses and other in the consolidated balance sheets. Returns are included in returned goods reserve in the consolidated balance sheets. Government Rebates are included in accrued government rebates in the consolidated balance sheets.
Schedule of property, plant and equipment, useful life

Buildings and improvements

  

20

-

40

 

years

Machinery, furniture, and equipment

1

10

years

Schedule of Earnings per share, basic and diluted

Earnings per share for the years ended December 31, 2021, 2020, and 2019 are calculated for basic and diluted earnings (loss) per share as follows:

Basic

Diluted

(in thousands, except per share amounts)

Years Ended December 31, 

Years Ended December 31, 

  

2021

  

2020

  

2019

  

2021

  

2020

  

2019

Net (loss)/income

$

(42,603)

$

(22,548)

$

6,094

$

(42,603)

$

(22,548)

$

6,094

Net income allocated to participating securities

 

 

 

(97)

 

 

 

(97)

Dividends on Series A convertible preferred stock

(190)

(190)

Net (loss)/income allocated to common shares

$

(42,793)

$

(22,548)

$

5,997

$

(42,793)

$

(22,548)

$

5,997

Basic Weighted-Average Shares Outstanding

 

12,596

 

11,964

 

11,841

 

12,596

 

11,964

 

11,841

Dilutive effect of stock options and ESPP

 

 

 

103

Dilutive effect of Notes

96

Diluted Weighted-Average Shares Outstanding

 

12,596

 

11,964

 

12,040

(Loss)/Income per share

$

(3.40)

$

(1.88)

$

0.51

$

(3.40)

$

(1.88)

$

0.50

Schedule of revenue of revenue by geographic operations

The following table depicts our revenue by geographic operations during the following periods:

(in thousands)

Years Ended December 31, 

Location of Operations

    

2021

    

2020

    

2019

United States

$

211,893

$

202,881

$

199,663

Canada

 

4,243

 

5,594

 

6,884

Total Revenue

$

216,136

$

208,475

$

206,547

Schedule of property and equipment by geographic location

(in thousands)

Years Ended December 31, 

Location of Operations

    

2021

    

2020

    

2019

United States

$

211,893

$

202,881

$

199,663

Canada

 

4,243

 

5,594

 

6,884

Total Revenue

$

216,136

$

208,475

$

206,547